Literature DB >> 9052681

Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo.

R W Howell1, S M Goddu, V R Narra, D R Fisher, R E Schenter, D V Rao.   

Abstract

The biological effects of radionuclides that emit alpha particles are of considerable interest in view of their potential for therapy and their presence in the environment. The present work is a continuation of our ongoing effort to study the radiotoxicity of alpha-particle emitters in vivo using the survival of murine testicular sperm heads as the biological end point. Specifically, the relative biological effectiveness (RBE) of very low-energy alpha particles (3.2 MeV) emitted by 148Gd is investigated and determined to be 7.4 +/- 2.4 when compared to the effects of acute external 120 kVp X rays. This datum, in conjunction with our earlier results for 210Po and 212Pb in equilibrium with its daughters, is used to revise and extend the range of validity of our previous RBE-energy relationship for alpha particles emitted by tissue-incorporated radionuclides. The new empirical relationship is given by RBE alpha = 9.14 - 0.510 E alpha where 3 < E alpha < 9 MeV. The validity of this empirical relationship is tested by determining the RBE of the prolific alpha-particle emitter 223Ra (in equilibrium with its daughters) experimentally in the same biological model and comparing the value obtained experimentally with the predicted value. The resulting RBE values are 5.4 +/- 0.9 and 5.6, respectively. This close agreement strongly supports the adequacy of the empirical RBE-E alpha relationship to predict the biological effects of alpha-particle emitters in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052681      PMCID: PMC3321061     

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  32 in total

1.  In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles.

Authors:  D V Rao; V R Narra; R W Howell; G F Govelitz; K S Sastry
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

2.  Cell survival following multiple-track alpha particle irradiation.

Authors:  E L Lloyd; M A Gemmell; C B Henning; D S Gemmell; B J Zabransky
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-01

3.  The in vitro radiobiology of astatine-211 decay.

Authors:  A I Kassis; C R Harris; S J Adelstein; T J Ruth; R Lambrecht; A P Wolf
Journal:  Radiat Res       Date:  1986-01       Impact factor: 2.841

4.  Spermatogonial stem-cell renewal in the mouse.

Authors:  E F Oakberg
Journal:  Anat Rec       Date:  1971-03

5.  "Biological dosimetry" of radionuclides and radiation hazards.

Authors:  M E Gaulden
Journal:  J Nucl Med       Date:  1983-02       Impact factor: 10.057

6.  Radiation dose and biological effects to mouse testis from sodium 32P-phosphate.

Authors:  T A Mian; H J Glenn; T P Haynie; M L Meistrich
Journal:  Health Phys       Date:  1982-05       Impact factor: 1.316

7.  Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo.

Authors:  D V Rao; V R Narra; R W Howell; K S Sastry
Journal:  Radiat Res       Date:  1990-11       Impact factor: 2.841

8.  Relative biological effectiveness of 99mTc radiopharmaceuticals.

Authors:  V R Narra; K S Sastry; S M Goddu; R W Howell; S E Strand; D V Rao
Journal:  Med Phys       Date:  1994-12       Impact factor: 4.071

9.  Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.

Authors:  V R Narra; R W Howell; R S Harapanhalli; K S Sastry; D V Rao
Journal:  J Nucl Med       Date:  1992-12       Impact factor: 10.057

10.  Reduction in sperm levels after testicular irradiation of the mouse: a comparison with man.

Authors:  M L Meistrich; R C Samuels
Journal:  Radiat Res       Date:  1985-04       Impact factor: 2.841

View more
  13 in total

1.  A multi-port low-fluence alpha-particle irradiator: fabrication, testing and benchmark radiobiological studies.

Authors:  Prasad V S V Neti; Sonia M de Toledo; Venkatachalam Perumal; Edouard I Azzam; Roger W Howell
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

Review 2.  Targeted alpha-therapy: past, present, future?

Authors:  Martin W Brechbiel
Journal:  Dalton Trans       Date:  2007-09-11       Impact factor: 4.390

3.  Biological response to nonuniform distributions of (210)Po in multicellular clusters.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  Radiat Res       Date:  2007-09       Impact factor: 2.841

4.  Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.

Authors:  Robert F Hobbs; Roger W Howell; Hong Song; Sébastien Baechler; George Sgouros
Journal:  Radiat Res       Date:  2014-01       Impact factor: 2.841

5.  Dosimetry of 223Ra-chloride: dose to normal organs and tissues.

Authors:  Michael Lassmann; Dietmar Nosske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-11       Impact factor: 9.236

6.  Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

Authors:  Kwon Yong; Martin W Brechbiel
Journal:  Dalton Trans       Date:  2011-03-04       Impact factor: 4.390

7.  Effects of radiation type and delivery mode on a radioresistant eukaryote Cryptococcus neoformans.

Authors:  Igor Shuryak; Ruth A Bryan; Jack Broitman; Stephen A Marino; Alfred Morgenstern; Christos Apostolidis; Ekaterina Dadachova
Journal:  Nucl Med Biol       Date:  2015-03-11       Impact factor: 2.408

8.  Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximab.

Authors:  Jostein Dahle; Thora J Jonasdottir; Helen Heyerdahl; Jahn M Nesland; Jørgen Borrebaek; Anne Kristine Hjelmerud; Roy H Larsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

9.  MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.

Authors:  George Sgouros; John C Roeske; Michael R McDevitt; Stig Palm; Barry J Allen; Darrell R Fisher; A Bertrand Brill; Hong Song; Roger W Howell; Gamal Akabani; Wesley E Bolch; A Bertrand Brill; Darrell R Fisher; Roger W Howell; Ruby F Meredith; George Sgouros; Barry W Wessels; Pat B Zanzonico
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

10.  203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.

Authors:  Yubin Miao; Said D Figueroa; Darrell R Fisher; Herbert A Moore; Richard F Testa; Timothy J Hoffman; Thomas P Quinn
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.